# Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis

> **NCT00246324** · PHASE4 · COMPLETED · sponsor: **Louisiana State University Health Sciences Center Shreveport** · enrollment: 16 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta 1a, oral doxycycline

## Key facts

- **NCT ID:** NCT00246324
- **Lead sponsor:** Louisiana State University Health Sciences Center Shreveport
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2009-08
- **Final completion:** 2009-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246324, "Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00246324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*